Table 3. Process and performance values in screening for cervical cancer in the 18 European countries.
|
Detection rate (%) |
|||||
|---|---|---|---|---|---|
| Country/region | Population subject to formal programme (in ages 25–64 years unless specified) | Women screened within recommended interval (%), any smears included (in ages 25–64 years in 2000 unless specified) | Invasive (ICC) | CIN3 | CIN1-2 |
| Czech republic | No data | No data | No data | No data | No data |
| Denmark | 90% (23–59) | 75% (23–59, 1997) | No data | No data | No data |
| Finland | 100% (30–60) | 93% (35–64, 1997) | 0.01 | 0.13 | 0.21 |
| Hungary | No data | 30% | No data | No data | No data |
| Iceland | 100% | 76% within a 3-year interval (25–69) | 0.015 | 0.47 | 0.27 |
| Lithuania | No data | No data | No data | No data | No data |
| Luxembourg | No data | 39% (1 year, 1999)a | No data | No data | No data |
| Netherlands | 100% (30–60)b | 77% (30–60, 1997)b | No data | 0.35 (incl. CIN3+) | 0.13 |
| Norway | 100% | 70% | 0.04c | 0.50c | 0.79c |
| Slovakia | No data | No data | No data | No data | No data |
| Slovenia | 31% in 2000 | 70% | No data | No data | No data |
| Sweden | 100%b | 83 (23–59; 1997)b | No data | No data | No data |
| Switzerland | No data | No datad | No data | No data | No data |
| UK | 100% | 83% | No data | No data | No data |
| France | |||||
| Bas-Rhin | No data | 69%e | 0.05 | 0.35 | 0.73 |
| Doubs | 88% | >50% | No data | No data | No data |
| Isére | No data | 69% (50–69, 1996) | No data | No data | No data |
| Germany | |||||
| Saarland | 90%b | 50% per year (20+; 1996); 80% within 3 yearsb | No data | No data | No data |
| Italy | |||||
| Florence | 100% | 73% | 0.008 | 0.13 | 0.12 |
| Genova | No data | 53%f | No data | No data | No data |
| Parma | 100% | 66% | No data | No data | No data |
| Ragusa | No data | 53%f | No data | No data | No data |
| Torino | 100% | >74% | 0.011 | 0.09 | 0.14 |
| Varese | No data | 53%6 | No data | No data | No data |
| Spain | |||||
| Catalonia | No data | No data | 0.04 | 0.06 | 0.8 |
a
From Scheiden et al (2000).
b
From Van Ballegooijen et al (2000); whole Germany.
c
In 1998, from The Cancer Registry of Norway (2001).
d
80% ever-screened (18–75; 1997).
e
From Schaffer et al (2000).
f
No regional data. Italian national estimate 1999/2000.